| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 205,368 | 264,926 | 664,141 | 642,474 | | Cost of Revenue | 63,062 | 113,250 | 230,520 | 70,858 | | | Gross Profit | 142,306 | 151,676 | 433,621 | 571,616 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 167,201 | 87,068 | 242,688 | 392,104 | | Non Recurring | 1,493 | 60,977 | 776,536 | 867 | | Others | 228,514 | 12,214 | 29,703 | 28,762 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (254,902) | (8,583) | (615,306) | 149,883 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,028) | (24,639) | (113,949) | 761 | | Earnings Before Interest And Taxes | (256,349) | (19,427) | (721,712) | 162,833 | | Interest Expense | 246 | (58) | 4,874 | 5,832 | | Income Before Tax | (256,595) | (19,369) | (726,586) | 157,001 | | Income Tax Expense | (35,748) | (7,784) | (219,786) | 50,874 | | Minority Interest |
-
| 111 | (24,441) | (22,293) | | | | Net Income From Continuing Ops | (220,847) | (11,474) | (531,241) | 83,834 | | | Non-recurring Events | | Discontinued Operations |
-
| (1,144) |
-
| 234 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (220,847) | (12,618) | (531,241) | 84,068 | | Preferred Stock And Other Adjustments | 147 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($220,700) | ($12,618) | ($531,241) | $84,068 |
|
0.45% Nasdaq 
0.20%
Income Statement
